Position in GRFS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$138,497
New position
Shares Held
17,269
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $1,341,272,655 across 18 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,276,418 | $312,007,615 | |
| 2 | LLY |
ELI LILLY & Co
|
303,295 | $278,961,642 | |
| 3 | ABBV |
AbbVie Inc.
|
1,000,714 | $217,645,287 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,222,577 | $147,063,787 | |
| 5 | AMGN |
Amgen Inc
|
319,923 | $112,564,907 | |
| 6 | PFE |
Pfizer Inc
|
3,488,515 | $97,957,501 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
992,662 | $60,204,950 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
258,398 | $36,012,929 |
All Filings in GRFS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $138,497 | 17,269 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||